Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasms × ulipristal acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leiomyoma 14 Infertility 2 Uterine Hemorrhage 1 Menorrhagia 1 Breast Neoplasms 1

Interventions

Trastuzumab 494 Paclitaxel 464 Cyclophosphamide 460 Docetaxel 406 Capecitabine 339 Letrozole 289 Fulvestrant 254 Doxorubicin 239 Carboplatin 222 Tamoxifen 211 Anastrozole 177 Radiotherapy 173 exemestane 171 Epirubicin 169 Bevacizumab 161 Lapatinib 141 Vinorelbine 139 Gemcitabine 137 pembrolizumab 135 pertuzumab 134 palbociclib 120 Exercise 108 Fluorouracil 100 Albumin-Bound Paclitaxel 99 Magnetic Resonance Spectroscopy 98 eribulin 94 130-nm albumin-bound paclitaxel 87 Everolimus 84 Cisplatin 79 Taxes 76

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02408770 2023-05-06

BC-APPS1

Manchester University NHS Foundation Trust

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡